Please assess the completion status of the following clinical trial:

Trial Title: The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with stable chronic coronary artery disease scheduled for elective percutaneous intervention.~Exclusion Criteria:~* Recent (1 month) myocardial infarction~* Acute coronary syndrome~* Chest pain at res~* Estimated glomerular filtration rate(GFR)\<45 mL/min/1.73 m2~* Frequent premature atrial or ventricular contractions or atrial fibrillation~* Any contraindication to MRI including implanted non MRI compatible medical devices or ferromagnetic materials such as shrapnel~* Inability to breath-hold~* Severe claustrophobia~* Deafness~* Persistent tremor~* Inability to follow instructions.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Remote Ischemic Preconditioning (RIPC) (Type: EXPERIMENTAL): Randomized subjects who are treated immediately prior to stenting with remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff inflations to occlude the brachial artery in their nondominant arms, with intervening 5 minute rest periods.
- Sham Remote Ischemic Preconditioning (Type: PLACEBO_COMPARATOR): Patients who prior to stenting have the RIPC blood pressure cuff placed but not inflated for 3 5 minute episodes with 5 minute rest periods.

Based on this trial design, predict the completion outcome and termination type (if applicable).